Scientists have made the first viruses designed by artificial intelligence in a milestone that raises hopes for new medicines but also concerns over how to ensure the technology remains safe.
The viruses are specific kinds known as bacteriophages, which only infect bacteria and are used around the world to treat patients with persistent infections. In lab tests, a cocktail of the AI-designed viruses killed E coli bugs that were resistant to natural bacteriophages.
Dr Brian Hie, a chemical engineer at Stanford University in California, used genome language models, the genetic equivalent of the large language models behind AI chatbots, to design functioning genomes for bacteriophages. The viruses were then made in the laboratory and pitted against E coli in a dish.
The ability to “rapidly design” genomes and tune them for specific bugs while overcoming resistance could “transform phage therapy” and “expand biotechnological toolkits”, the researchers wrote in the journal Science.
But beyond the potential benefits, the scientists said the work raised “important biosafety, biocontainment and biosecurity considerations” and urged others who were designing whole genomes to “consult both safety and security professionals throughout the project”.
To read more, see The Guardian.
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)
No comments:
Post a Comment
Pharmaceutical Microbiology Resources